Loring Wolcott & Coolidge Fiduciary Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-59
Closed -$6K 791
2021
Q3
$6K Hold
59
﹤0.01% 651
2021
Q2
$6K Buy
+59
New +$6K ﹤0.01% 730